PAG
RDY icon

Private Advisor Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Private Advisor Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,000
Closed -$64K – 3010
2020
Q2 		$64K Buy
+6,000
New +$61K ﹤0.01% 1959

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Private Advisor Group's RDY Position: Q3 2020 in Review

Private Advisor Group sold out of Dr. Reddy's Laboratories (RDY) in Q3 2020, closing a stake of 6,000 shares — an estimated $64K sold.

Private Advisor Group first reported a position in RDY in Q2 2020 and held it in 1 quarter. The position peaked at $64K in Q2 2020. 186 funds tracked by Wall St. Rank hold RDY as of Q3 2020.

  • Private Advisor Group reported no remaining Dr. Reddy's Laboratories position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 6,000 Dr. Reddy's Laboratories shares in Q3 2020, an estimated $64K.
  • Private Advisor Group first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Dr. Reddy's Laboratories position peaked at $64K in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.